Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets
Shares of Biocon surged as much as 5 per cent during the trading session on Monday after the USFDA cleared Malaysia unit to ...
Biocon stock soars 4% after USFDA clears Malaysia unit, ends regulatory hurdles
Clearance of Biocon's Malaysia unit puts an end to the drugmaker's regulatory hurdles and opens the door for the approval and ...
Biocon surges after Malaysian facility gets classified as VAI by the US FDA
Biocon jumped 4.03% to Rs 375.40 after the company said that the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' Insulins facilities in Johor Bahru, Malaysia as voluntary ...
Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility
Biocon share price rose 4.5% following US FDA clearance for its Malaysian insulin facility, resolving a regulatory bottleneck ...